Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Swine influenza – pipeline review, h2 2012
1. Swine Influenza – Pipeline Review, H2 2012
Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Swine Influenza – Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Swine Influenza - Pipeline Review, H2 2012, provides an
overview of the Swine Influenza therapeutic pipeline. This report provides
information on the therapeutic development for Swine Influenza, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Swine Influenza.
Swine Influenza - Pipeline Review, H2 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Swine Influenza.
- A review of the Swine Influenza products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
2. Swine Influenza – Pipeline Review, H2 2012
therapeutics.
Table of contents:
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Swine Influenza Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Swine Influenza 10
Swine Influenza Therapeutics under Development by Companies 12
Swine Influenza Therapeutics under Investigation by Universities/Institutes 16
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Pre-Clinical Stage Products 21
Comparative Analysis 21
Swine Influenza Therapeutics – Products under Development by Companies 22
Swine Influenza Therapeutics – Products under Investigation by
Universities/Institutes 26
Companies Involved in Swine Influenza Therapeutics Development 28
Baxter International Inc. 28
Johnson & Johnson 29
Vical Incorporated 30
GlaxoSmithKline plc 31
Inovio Biomedical Corporation 32
Celltrion, Inc. 33
Novartis AG 34
Novavax, Inc. 35
CEL-SCI Corporation 36
AVI BioPharma Inc. 37
Crucell N.V. 38
OPKO Health, Inc. 39
3. Swine Influenza – Pipeline Review, H2 2012
Medicago Inc. 40
NovaBay Pharmaceuticals, Inc. 41
XOMA Ltd. 42
Lipoxen PLC 43
Green Cross Corporation 44
Synairgen plc 45
Antigen Express, Inc. 46
Colby Pharmaceutical Company 47
Marinomed Biotechnologie GmbH 48
LigoCyte Pharmaceuticals, Inc. 49
TechnoVax, Inc. 50
AlphaVax, Inc. 51
Theraclone Sciences, Inc. 52
REPLICor Inc. 53
Protein Sciences Corporation 54
Etubics Corporation 55
iBio, Inc. 56
Avir Green Hills Biotechnology AG 57
Sirnaomics, Inc. 58
Vaxart, Inc. 59
NasVax Ltd. 60
ImmuneRegen BioSciences, Inc. 61
Vivaldi Biosciences Inc. 62
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1